Drug Profile
Research programme: c-Met inhibitors - Spirogen
Alternative Names: AG-213Latest Information Update: 10 Aug 2021
Price :
$50
*
At a glance
- Originator Spirogen
- Class Small molecules
- Mechanism of Action Proto-oncogene protein c-met inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Cancer in United Kingdom
- 17 May 2007 Preclinical trials in Cancer in United Kingdom (unspecified route)